This inventor holds 19 USPTO granted patents and 11 published patent applications and 4 EPO patents, primarily in Muscle Dystrophy Treatment. Top assignees: Avidity Biosciences, Inc., Vertex Pharmaceuticals, Inc.. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Areas of Expertise:
Title: Inventor Gulin Erdogan Marelius: A Pioneer in Pharmaceutical Innovations
Introduction
Gulin Erdogan Marelius is a notable inventor based in San Diego, CA, who has significantly contributed to the field of pharmaceuticals with a remarkable portfolio of 17 patents. His inventive spirit is evident through his groundbreaking research and innovative therapies aimed at treating complex medical conditions.
Latest Patents
Among his latest patents, one noteworthy invention is focused on compositions and methods for treating muscle atrophy and myotonic dystrophy. This patent discloses polynucleic acid molecules and pharmaceutical compositions designed to combat these debilitating muscle disorders. Another significant invention by Marelius involves modulators of the cystic fibrosis transmembrane conductance regulator (CFTR). This invention presents a compound formula intended for the treatment of CFTR-mediated diseases, such as cystic fibrosis, along with associated pharmaceutical compositions and kits.
Career Highlights
Marelius has made substantial strides in his career, working with renowned companies in the biopharmaceutical sector. He has held positions at Avidity Biosciences, Inc. and Vertex Pharmaceuticals, Inc., where he has been instrumental in advancing research and developing new therapies. His commitment to innovation has earned him recognition within the scientific community.
Collaborations
Throughout his career, Marelius has collaborated with talented individuals in the field, including Venkata Ramana Doppalapudi and Michael Caramian Cochran. These partnerships have fostered a collaborative environment that supports the development of cutting-edge solutions for challenging health issues.
Conclusion
Gulin Erdogan Marelius's contributions to the pharmaceutical industry underscore the importance of innovation and collaboration in the quest for effective medical treatments. His impressive number of patents is a testament to his dedication to improving patient outcomes through science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile